• Wion
  • /World
  • /Bharat Biotech announces Covaxin's efficacy rate after final stage trials - World News
Bharat Biotech announces Covaxin's efficacy rate after final stage trials

Bharat Biotech announces Covaxin's efficacy rate after final stage trials

Bharat Biotech said that it has concluded the final analysis for its COVID-19 vaccine Covaxin as part of phase-3 clinical trials. The Hyderabad-based pharma company claimed that its indigenous jab demonstrates an overall efficacy of 77.8% against symptomatic infection.